Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thames Ventures VCT 2 is a London-listed venture capital trust (VCT) managed by Foresight Group that provides venture capital to early-stage and high-growth companies in the United Kingdom. The trust maintains a dedicated Healthcare share class, which specifically targets investments in the life sciences, medical technology, diagnostics, and digital health sectors. Formerly known as Downing FOUR VCT, the fund aims to provide retail investors with tax-efficient exposure to a diversified portfolio of private and AIM-listed healthcare businesses. Its investment strategy focuses on supporting companies through clinical development, regulatory approval, and international commercial expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thames Ventures VCT 2.